共 230 条
[1]
Asamura H(2008)A Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers J Thorac Oncol 3 46-52
[2]
Goya T(2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 351-360
[3]
Koshiishi Y(2005)Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2589-2597
[4]
Sohara Y(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (adjuvant navelbine international trialist association [ANITA]): a randomised controlled trial Lancet Oncol 7 719-727
[5]
Eguchi K(2008)Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group J Clin Oncol 26 3552-3559
[6]
Mori M(2012)Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in Japan Respir Investig 50 157-161
[7]
Nakanishi Y(2011)Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade J Thorac Oncol 6 1229-1235
[8]
Tsuchiya R(2015)Randomized phase II study of adjuvant chemotherapy with long-term S-1 versus cisplatin+ S-1 in completely resected stage II–IIIA non-small cell lung cancer Clin Cancer Res 21 5245-5252
[9]
Shimokata K(2014)Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer Cancer Chemother Pharmacol 74 1199-1206
[10]
Inoue H(1985)The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 1604-1608